Healthcare reform profited lobbying firms

by Emily P. Walker

In the postgame wrap-up on healthcare reform, analysts say the big winners are lobbyists, who managed to earn record amounts during the more than year-long battle.

About 1,750 businesses and organizations spent $1.2 billion in 2009 to lobby for their positions on healthcare reform and other legislative issues, according to a new study from the Center for Public Integrity (CPI).

An exact breakdown of how much money lobbyists made specifically on healthcare reform isn’t available because they aren’t required to itemize the amount spent on each policy issue. But researchers with CPI estimated that if just 10% of all lobby spending went toward healthcare, that would total $120 million, which could well be a record for the amount of money spent on a single issue in one year.

The largest lobbying shop on K Street, Patton Boggs, represented more clients on healthcare issues than any other firm — 53, according to CPI. The firm received $7.68 million from clients that included Bristol-Myers Squibb for lobbying on healthcare and other issues.

The only lobbyist willing to speak on the record, a partner at Foley Hoag, told CPI that the majority of the firm’s heatlhcare clients — 32 in all — were pharmaceutical companies. They included Pfizer, Eli Lilly, Merck, and Amgen. According to the CPI report, which was based on an analysis of Senate lobby disclosure documents, clients spent $4,064,500 on healthcare and other issues

Ken Gross, a Washington lawyer and lobbying expert, told CPI that he thinks the amount of money spent on healthcare reform is unprecedented.

“First of all, [the debate] went on for so long,” Gross told CPI. “Second of all, it was high-stakes poker. It stands to reason that it would be a record-breaker.”

Emily P. Walker is a MedPage Today Washington Correspondent.

Originally published in MedPage Today. Visit MedPageToday.com for more health policy news.

email

  • http://fertilityfile.com IVF-MD

    The 120 million went to pay for the time and energy of the lobbyists in exchange for the work they did. Now this work, time and energy did not result in a single person being cured of a disease, anybody being relieved of pain nor in people receiving the satisfaction of speaking with a health care provider. In contrast, it went to the wasted tug-of-war of determining who is forced to give up their earnings (in this case it’s all tax-paying Americans) and who gets how big a chunk of that bounty (in this case, according to the article, pharma, but there are obviously other corporations who benefit as well). Meanwhile, as the middlemen, politicians and their campaigns along with the lobbyists also share in a chunk of that pot of money, while the losers are the general public.

    Do we want a society where ones wealth and prosperity comes about from who can more successfully exploit the power of elected officials to force other people to give up their money and rights involuntarily? Or do we want a society where ones wealth and prosperity are dependent on providing value to others, so much so that the others willingly and gladly pay in exchange for the benefits that the providers give them?

    The answer is not a simple one. From an ethical point of view, the latter is the moral way. From a reality point of view, if you are one of the special interest groups that is especially adept at exploiting the system, then of course your self-interest would have you loving the former system.

    The sad thing is that for society as a whole, the more we move towards a society where power is based on political manipulations as opposed to one based on voluntary non-coercive free-exchange, the lower our overall standard of living will become.

    There are several obvious reasons this is true. But there are actually many less obvious, indirect reasons as well. And those of you psychologists, sociologists and economists out there can probably name a lot more of these reasons than I can.

  • Doc99

    So far, the biggest loser, other than the US Constitution, is the AMA.

Trending